BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1358031)

  • 1. [Genetic alterations in the genesis and development of ovarian cancer].
    Okamoto A; Yokoyama S; Terashima Y
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T; Takahashi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
    Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
    Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alterations of oncogenes in human cancers].
    Tsuda H; Hirohashi S
    Gan To Kagaku Ryoho; 1993 May; 20(7):977-83. PubMed ID: 8098201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
    Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
    Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes in ovarian cancer.
    Berchuck A; Kohler MF; Bast RC
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):813-27. PubMed ID: 1500387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular biology in gastric cancer].
    Kikuchi K; Ueda M; Kitajima M
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2139-46. PubMed ID: 10635296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of prognostic factors in gynecological cancer examined by molecular biological study].
    Nagai N
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1004-9. PubMed ID: 8687214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in the ovary.
    Berchuck A
    J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes and antioncogenes in human breast carcinoma.
    Leslie KO; Howard P
    Pathol Annu; 1992; 27 Pt 1():321-42. PubMed ID: 1346552
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial ovarian cancer.
    Buller RE; Anderson B; Connor JP; Robinson R
    Gynecol Oncol; 1993 Nov; 51(2):160-6. PubMed ID: 7903948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.
    Rhei E; Bogomolniy F; Federici MG; Maresco DL; Offit K; Robson ME; Saigo PE; Boyd J
    Cancer Res; 1998 Aug; 58(15):3193-6. PubMed ID: 9699640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology of human ovarian cancer.
    Chow SN; Chien CH; Chen CT
    Int Surg; 1996; 81(2):152-7. PubMed ID: 8912082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.